Zymeworks ZYME
NASDAQ ZYME
$27.20 +0.08 (+0.29%)
At close: Sep 29, 2026 · 4:00 PM EDT

Zymeworks (ZYME) EV to EBITDA (2022 - 2023)

Updated

Zymeworks' (ZYME) EV to EBITDA came in at 0.63 for Q3 2023, down 49.6% from the prior quarter.

Analysis

Zymeworks (ZYME) EV to EBITDA (2022 - 2023) Analysis & Trends

For the trailing twelve months through Sep 30, 2023, EV to EBITDA at Zymeworks was -4.84; for FY2022, it came in at 0.02.

  • Quarterly EV to EBITDA has run from a low of 0.02 in Q4 2022 to a high of 1.30 in Q1 2023 over five years.
  • According to Business Quant data, EV to EBITDA for the three prior quarters was 1.25 (Q2 2023), 1.30 (Q1 2023) and 0.02 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Zymeworks 1.94 Bn 820.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 0.63
Jun 30, 2023 1.25
Mar 31, 2023 1.30
Dec 31, 2022 0.02
API Access

Zymeworks EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ZYME&period=max&api_key=YOUR_API_KEY